SCHEMBL6674092

SCHEMBL6674092

CC(C)N1CCC(Oc2ccc3c(c2)CCN(C(=O)O)CC3C(C)(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 20/20 0.48
▸ CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6672761 0.86 HRH3 (0.45) HRH3
SCHEMBL6673737 0.86 F10 (0.44) HRH3
SCHEMBL6674094 0.83 HRH3 (0.48) HRH3
SCHEMBL5551729 0.81 ESR1 (0.47) —
SCHEMBL6674044 0.81 F10 (0.49) HRH3
SCHEMBL5713459 0.78 GHSR (0.44) HRH3
SCHEMBL2121244 0.78 ESR1 (0.40) —
SCHEMBL4637682 0.76 NR1H2 (0.46) —
SCHEMBL2124644 0.75 ESR2 (0.45) —
SCHEMBL5165131 0.75 GRIN1 (0.54) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004035544-A1 BENZO[D]AZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS GLAXO GROUP LIMITED (GB) 2004-04-29 — — WO disclosed
Send feedback